The DEA begins reviewing its proposal to move cannabis to Schedule III, even as reform advocates criticize their exclusion ...

Both a DEA lawyer and an FDA official spoke to justify rescheduling—arguments that were condemned by a prominent ...

The Fresh Toast - What happened on day two of the marijuana rescheduling hearing? Learn what is at stake and who testified.

The DEA is meant to fill the role of defending the reform, while only opponents of resecheduling have been invited to ...

Last December, President Trump signed an executive order calling for the rescheduling of marijuana. The DEA is now ...

The DEA's cannabis rescheduling hearing runs through a July 15 deadline, putting cannabis stocks and the MSOS ETF in focus.

The cannabis industry won't have a direct voice in potentially historic hearings next week. And a final outcome is far from certain.

Fox News senior medical analyst Dr. Marc Siegel discusses the DEA's marijuana rescheduling hearings, warning about its ...

This may be an encouraging sign for those advocating for the rescheduling of cannabis in a way that will survive the inevitable legal challenge(s) that would follow rescheduling.” By Brett Schuman and ...

There was no discussion of the lasting harms of marijuana criminalization itself—the arrests, convictions, incarceration and collateral consequences that continue to affect individuals, families and ...

As the U.S. Drug Enforcement Administration (DEA) gears up for its administrative hearing on the fate of federal marijuana ...

The Drug Enforcement Administration is considering a proposal to move marijuana from Schedule I to Schedule III of the ...